BIOSIMILARS

作品数：20被引量：6H指数：1
导出分析报告
相关领域：医药卫生经济管理更多>>
相关期刊：《World Journal of Clinical Cases》《Journal of Chinese Pharmaceutical Sciences》《Global Health Research and Policy》《Cancer Innovation》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Comparison and Suggestions on the Registration and Regulation of Biosimilars between China and the USA
《Asian Journal of Social Pharmacy》2025年第1期28-37,共10页Cao Yizhi Lian Guiyu 
Objective To put forward some suggestions for improving the registration and regulation,the efficiency of evaluation,and approval of biosimilar in China so as to promote the development of biopharmaceutical industry a...
关键词：BIOSIMILAR registration and regulation REVIEW approve 
Real-world experience and long-term outcomes of a mandatory nonmedical switch of adalimumab originator to biosimilars in inflammatory bowel disease
《World Journal of Gastroenterology》2024年第46期4904-4913,共10页Jeremy Liu Chen Kiow Thomas Hoang Harjot K Bedi Zhina Majdzadeh Ardekani Daniel Rosenfeld Marica Reise-Filteau Brian Bressler Yvette Leung Greg Rosenfeld 
BACKGROUND Over the last decade,the treatment options for inflammatory bowel disease(IBD)have significantly progressed with the emergence of new medications designed to target various immune pathways and mitigate infl...
关键词：Inflammatory bowel disease Ulcerative colitis Crohn’s disease BIOLOGICS ADALIMUMAB Biosimilar switch 
Uptake of biosimilars in China:a retrospective analysis of the case of trastuzumab from 2018 to 2023
《Global Health Research and Policy》2024年第1期139-150,共12页Qiyou Wu Zhitao Wang Yihan Fu Ren Luo Jing Sun 
Peking Union Medical College[Fund(2019)No.22]。
Background The Chinese biosimilar industry has demonstrated rapid growth in recent years.Limited evidence is available about biosimilar uptake at the national level.This study aimed to assess biosimilar uptake in the ...
关键词：BIOSIMILARS TRASTUZUMAB Market dynamics Market competitions UPTAKE 
Cancer treatment with biosimilar drugs:A review
《Cancer Innovation》2024年第2期45-62,共18页Shilpa Malakar Emmanuel Nuah Gontor Moses YDugbaye Kamal Shah Sakshi Sinha Priya Sutaoney Nagendra Singh Chauhan 
Director of AYUSH(Chhattisgarh)for laboratory facilities and National Ayush Mission(NAM)Grant award year 2016-17。
Biosimilars are biological drugs created from living organisms or that contain living components.They share an identical amino-acid sequence and immunogenicity.These drugs are considered to be cost-effective and are u...
关键词：BIOLOGICS BIOSIMILARS cancer Escherichia coli monoclonal antibody next-generation sequencing PHARMACOVIGILANCE 
Analytical Method Development and Validation of Some Biosimilar Drugs by High Performance Thin Layer Chromatography
《American Journal of Analytical Chemistry》2023年第3期121-133,共13页Husna Kanwal Qureshi Ciddi Veeresham 
A simple and rapid HPTLC analytical method has been developed and validated for the determination of Etanercept and Filgrastim in pure form and in marketed formulation. Both the drugs were chromatographed on silica ge...
关键词：BIOSIMILARS ETANERCEPT FILGRASTIM Method Development Validation 
Familiarity, Knowledge and Practices of Healthcare Professionals Regarding the Pharmacovigilance of Biological Medicines in Lusaka, Zambia: A Multi-Facility Cross-Sectional Study
《Pharmacology & Pharmacy》2022年第7期230-251,共22页Michelo Banda Katia Verhamme Webrod Mufwambi Steward Mudenda Billy Chabalenge Scott Kaba Matafwali Ronald Kampamba Mutati Christabel Nang’andu Hikaambo Martin Kampamba Lavina Prashar 
Background: Pharmacovigilance of biological medicines is crucial because it ensures that medicines meet the World Health Organization (WHO) standards. In Zambia, there is little information on healthcare professionals...
关键词：PHARMACOVIGILANCE Biological Medicines BIOSIMILARS BRAND BATCH Zambia 
Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
《World Journal of Clinical Cases》2022年第14期4327-4333,共7页Hala Najeeb Farah Yasmin Salim Surani 
The increasing incidence of inflammatory bowel disease(IBD)globally has redirected the healthcare system's focus towards safe and affordable pharmacological interventions.The inception of anti-tumor necrosis factor-α...
关键词：Inflammatory bowel disease BIOSIMILARS Anti-tumor necrosis factor INFLIXIMAB ADALIMUMAB Ulcerative colitis Chrons disease 
Analytical Method Development and Validation of Etanercept by UV and RP-UFLC Methods
《American Journal of Analytical Chemistry》2021年第12期493-505,共13页Husna Kanwal Qureshi Ciddi Veeresham Chinta Srinivas 
The research work was carried out using Ultraviolet (UV)—visible spectroscopy and Reverse Phase-Ultra Fast Liquid Chromatography (RP-UFLC) for establishing novel methods for the analysis and quantification of Biosimi...
关键词：BIOSIMILARS ETANERCEPT Etacept® RP-UFLC UV Spectroscopy VALIDATION 
Analytical Method Development and Validation of Filgrastim by UV and RP-UFLC Methods被引量：1
《American Journal of Analytical Chemistry》2021年第10期333-346,共14页Husna Kanwal Qureshi Ciddi Veeresham Chinta Srinivas 
The research work was carried out for establishing a new Ultra Violet (UV)— Visible spectroscopy and Reverse phase-Ultra Fast Liquid Chromatography (RP-UFLC) method for the analysis and quantification of a biosimilar...
关键词：BIOSIMILARS Filgastim Method Development RP-UFLC UV Visible Spectroscopy VALIDATION 
Clinical Profile of Carcinoma Breast Patients Treated with Trastuzumab: A Single Centre Study
《Advances in Breast Cancer Research》2020年第4期110-118,共9页Srinivasa Belagutty Jayappa Bhanu Prakash Lalkota Veluswamy Mani Reshma Elsa Jenny Kiran P. Krishnamurthi Vinu Sarathy S. Thineshwaran Bayas Nithin Sumithra Martinovic Amritanshu Ram Shekar Patil Radheshyam Naik 
Introduction: Breast cancer is the most common female cancer in India and accounting由于版权政策及相关保密法规原因，条结果未予显示。
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部